10 results · 26ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

AVAIRA AVAIRA TORIC AVAIRA MULTIFOCAL

FDA 510(k)
FDA Class 2 ·Ophthalmic

CapSure® Spine System

FDA UDI
Spine Wave, Inc.·10840642104400·Rod Straight 5.5 x 45mm

UniTip High Resolution Catheter

FDA UDI
Unisensor AG·07640172970577·

UNITED UTF STEM

FDA 510(k)
FDA Class 2 ·Orthopedic

CELSTAT

FDA 510(k)
FDA Unclassified ·Unknown

8800

FDA Adverse Event
Malfunction ·GE OEC MEDICAL SYSTEMS (SLC)·Product code JAA·May 8, 2013

PALMAZ GENESIS AMIIA

FDA Adverse Event
Injury ·CORDIS DE MEXICO·Product code FGE·September 24, 2014

GYNECARE X-TRACT MORCELLATOR

FDA Adverse Event
Malfunction ·ETHICON·Product code HET·June 3, 2011

Ventec Life Systems VOCSN Multi-Function Ventilator Model/Version/Catalog Number: V+O+C+S+N+Pro/English/PRT-00490-001; V+O+C+S+N+Pro/Japan/PRT-00490-100; V+C+Pro/English/PRT-00900-001; V+C+Pro/Japan/PRT-00900-100; V+C/English/PRT-01098-000; V+O+C+S+N/English/PRT-01100-000; V+O+C+S+N/English/PRT-01100-001;

FDA Enforcement
Class II ·Ongoing·Ventec Life Systems, Inc.·June 30, 2021

Stryker T2 Arthrodesis Nailing System. Manufacturer: Stryker Trauma GmbH, Professor-Kuntscher-Str. 1-5, 24232 Schonkirchen Germany. Distributed in the USA by Stryker Orthopaedics, 325 Corporate Drive, Mahwah, NJ 07430. The T2 Arthrodesis Nail is intended for the treatment of Knee Arthrodesis. The design of the T2 Arthrodesis Nail features a unique curvature which incorporates both femur ante curvature and knee valgus bend. Indications: Aseptic failed total knee arthro-plasty with or without bone loss; Failed external fixation, non unions and malunions; Periarticular fractures where repair is not possible; Pathologic fractures and tumor resections; Pseudoarthrosis and correct osteotomy; Ipsilateral femur fractures; and Open and closed femoral fractures.

FDA Enforcement
Class II ·Terminated·Stryker Howmedica Osteonics Corp.·July 25, 2012